Melinta Therapeutics Cancels Presentation at The Cowen & Company 38th Annual Health Care Conference Due to Inclement Weather

World News: . []

NEW HAVEN, Conn., March 13, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ:MLNT), a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial infections, announced today that it has cancelled its presentation at the Cowen & Company 38th Annual Health Care Conference scheduled for Wednesday, March 14, 2018 in Boston, due to the severe weather that has been forecast for the region. Company President and CEO Dan Wechsler had been scheduled to speak.

Melinta will post the presentation material to the Events & Presentations section of its Investors webpage at .

Media Inquiries:Amra Maynard(917) 302-2702Amra.maynard@inventivhealth.com

Investor Inquiries:Lisa DeFrancesco(847) 681-3217ldefrancesco@melinta.com

Raj Mistry(312) 801-2051rmistry@melinta.com

More news and information about Melinta Therapeutics

Published By:

Globe Newswire: 20:35 GMT Tuesday 13th March 2018

Published: .

Search for other references to "melinta" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us
 

Advertising on SPi News: Information For Advertisers